Your browser doesn't support javascript.
loading
Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA).
Damschroder, Laura J; Reardon, Caitlin M; AuYoung, Mona; Moin, Tannaz; Datta, Santanu K; Sparks, Jordan B; Maciejewski, Matthew L; Steinle, Nanette I; Weinreb, Jane E; Hughes, Maria; Pinault, Lillian F; Xiang, Xinran M; Billington, Charles; Richardson, Caroline R.
Afiliación
  • Damschroder LJ; Ann Arbor VA HSR&D/Center for Clinical Management Research, P.O. Box 130170, Ann Arbor, MI, 48113-0170, USA. laura.damschroder@va.gov.
  • Reardon CM; VA Diabetes QUERI, Ann Arbor, MI, USA. laura.damschroder@va.gov.
  • AuYoung M; Ann Arbor VA HSR&D/Center for Clinical Management Research, P.O. Box 130170, Ann Arbor, MI, 48113-0170, USA.
  • Moin T; Ann Arbor VA HSR&D/Center for Clinical Management Research, P.O. Box 130170, Ann Arbor, MI, 48113-0170, USA.
  • Datta SK; Scripps Translational Science Institute/The Scripps Research Institute, 10550 North Torrey Pines Road, Mail Drop: TRY-30, La Jolla, CA, 92037, USA.
  • Sparks JB; VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd 3, Los Angeles, CA, 90073, USA.
  • Maciejewski ML; David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Steinle NI; Greater Los Angeles VA Health Services Research and Development (HSR&D) Center for Healthcare Innovation, Implementation and Policy, Los Angeles, CA, USA.
  • Weinreb JE; Durham VA Medical Center HSR&D, 411 W Chapel Hill St, Suite 600, Durham, NC, 27701, USA.
  • Hughes M; Duke University School of Medicine, Durham, NC, USA.
  • Pinault LF; Ann Arbor VA HSR&D/Center for Clinical Management Research, P.O. Box 130170, Ann Arbor, MI, 48113-0170, USA.
  • Xiang XM; Durham VA Medical Center HSR&D, 411 W Chapel Hill St, Suite 600, Durham, NC, 27701, USA.
  • Billington C; Duke University School of Medicine, Durham, NC, USA.
  • Richardson CR; VA Maryland Healthcare System, 10 North Greene St, Baltimore, MD, 21201, USA.
Implement Sci ; 12(1): 94, 2017 07 26.
Article en En | MEDLINE | ID: mdl-28747191
BACKGROUND: The Diabetes Prevention Program (DPP) is an effective lifestyle intervention to reduce incidence of type 2 diabetes. However, there are gaps in knowledge about how to implement DPP. The aim of this study was to evaluate implementation of DPP via assessment of a clinical demonstration in the Veterans Health Administration (VHA). METHODS: A 12-month pragmatic clinical trial compared weight outcomes between the Veterans Affairs Diabetes Prevention Program (VA-DPP) and the usual care MOVE!® weight management program (MOVE!). Eligible participants had a body mass index (BMI) ≥30 kg/m2 (or BMI ≥ 25 kg/m2 with one obesity-related condition), prediabetes (glycosylated hemoglobin (HbA1c) 5.7-6.5% or fasting plasma glucose (FPG) 100-125 mg/dL), lived within 60 min of their VA site, and had not participated in a weight management program within the last year. Established evaluation and implementation frameworks were used to guide the implementation evaluation. Implementation barriers and facilitators, delivery fidelity, participant satisfaction, and implementation costs were assessed. Using micro-costing methods, costs for assessment of eligibility and scheduling and maintaining adherence per participant, as well as cost of delivery per session, were also assessed. RESULTS: Several barriers and facilitators to Reach, Adoption, Implementation, Effectiveness and Maintenance were identified; barriers related to Reach were the largest challenge encountered by site teams. Fidelity was higher for VA-DPP delivery compared to MOVE! for five of seven domains assessed. Participant satisfaction was high in both programs, but higher in VA-DPP for most items. Based on micro-costing methods, cost of assessment for eligibility was $68/individual assessed, cost of scheduling and maintaining adherence was $328/participant, and cost of delivery was $101/session. CONCLUSIONS: Multi-faceted strategies are needed to reach targeted participants and successfully implement DPP. Costs for assessing patients for eligibility need to be carefully considered while still maximizing reach to the targeted population.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Department of Veterans Affairs / Diabetes Mellitus Tipo 2 / Sobrepeso / Estilo de Vida Saludable / Promoción de la Salud Tipo de estudio: Clinical_trials / Diagnostic_studies / Evaluation_studies / Prognostic_studies / Sysrev_observational_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Implement Sci Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Department of Veterans Affairs / Diabetes Mellitus Tipo 2 / Sobrepeso / Estilo de Vida Saludable / Promoción de la Salud Tipo de estudio: Clinical_trials / Diagnostic_studies / Evaluation_studies / Prognostic_studies / Sysrev_observational_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Implement Sci Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos